CMV Drives CD4 T Cell Aging While Rheumatoid Arthritis Blunts Their Function

Chronic immune stimulation is a hallmark of both persistent viral infections and autoimmune diseases, yet how these distinct triggers converge on T cell aging remains poorly understood. This study from the University of Pennsylvania used 36-marker mass cytometry (CyTOF) and functional assays to dissect the independent and combined effects of CMV infection and rheumatoid arthritis (RA) on senescent CD4+ T cells in 20 RA patients and 16 healthy controls, stratified by CMV serostatus.

CMV emerged as the dominant driver of CD27−CD28− CD4+ T cell expansion. UMAP clustering revealed a distinct, CMV-associated cluster (cluster 10) enriched for cytotoxic markers including granzyme B, perforin, CD57, CD94, 2B4, and CD11b—molecules typically associated with NK cells and cytotoxic CD8+ T cells. These cells also displayed features of terminal differentiation such as CD45RA re-expression (TEMRA phenotype). By contrast, CD27−CD28− CD4+ T cells from CMV-seronegative donors were rare and phenotypically distinct—lacking cytotoxic granules but showing markers of cellular activation (Ki67+HLA-DR+), suggesting a fundamentally different biology.

Intriguingly, CMV-reactive cells (identified by pp65 peptide stimulation and TNF-α/IFN-γ co-expression) were enriched within the CD27−CD28− compartment but accounted for only a minor fraction of it—pointing to bystander-driven differentiation as a major mechanism by which CMV reshapes the broader T cell repertoire. EBV and HSV seropositivity did not independently increase CD27−CD28− CD4+ T cell frequency, highlighting CMV's unique capacity to drive this phenotype.

RA alone did not increase the abundance of senescent CD4+ T cells, but in CMV-seropositive RA patients, these cells showed markedly impaired effector function—reduced pro-inflammatory cytokine production (TNF-α, IFN-γ) and diminished cytotoxic degranulation. This functional deficit was selective: central memory CD4+ T cells and terminally differentiated CD8+ T cells retained normal effector capacity in RA patients, and there was no evidence of CMV reactivation, suggesting that viral control remained intact via other T cell populations. These findings reveal that RA modulates T cell function in a subset-specific manner rather than causing broad immune suppression.

These results have important implications for understanding accelerated immunological aging in RA and the complex interplay between autoimmunity and chronic viral infections. The functional impairment of senescent CD4+ T cells in CMV+/RA patients could paradoxically reduce harmful inflammation while potentially compromising protective cytotoxic immunity. Future longitudinal studies should examine whether these functional deficits correlate with clinical outcomes such as infection susceptibility, cardiovascular risk, or disease activity.